This is underlined by data on intestinal IgA responses to gut microbes in patients with APS that showed that within the IgA coated fraction of the gut microbiome, both alpha and beta diversity differed between APS patients and healthy controls.5 This evidence concerns the gene CD79A and autoimmune polyendocrinopathy.